T 0259/23 (Small intestinal delivery of norovirus antigen / VAXART) of 06.02.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T025923.20250206
- Date of decision
- 6 February 2025
- Case number
- T 0259/23
- Petition for review of
- -
- Application number
- 16808196.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS
- Applicant name
- Vaxart, Inc.
- Opponent name
- iosBio Ltd
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 013(1)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Late-filed evidence - admitted (yes)
Sufficiency of disclosure - (yes)
Inventive step (yes)
Inventive step - no reasonable expectation of success - Catchword
- -
- Cited cases
- G 0002/21
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of auxiliary request 2 filed with the reply to the statement of grounds of appeal on 18 August 2023 and a description to be adapted thereto.